Abstract：Dronedarone is one of the new drugs for the treatment of atrial fibrillation. This paper briefly introduces the pharmacological characteristics of dronedarone and 6 phase Ⅲ clinical trials, aiming to guide clinical medication.
刘玉平, 赵文婷, 邹操, 李勋, 杨向军. 决奈达隆治疗心房颤动的循证依据和展望[J]. 实用心电学杂志, 2014, 23(5): 358-363.
LIU Yu-Ping, ZHAO Wen-Ting, ZOU Cao, LI Xun, YANG Xiang-Jun. Dronedarone in treating atrial fibrillation: the prospects and evidences. JOURNAL OF PRACTICAL ELECTROCARDIOLOGY, 2014, 23(5): 358-363.
\[1\] Fuster V, Rydén LE, Cannom DS ,et al.2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society\[J\].J Am Coll Cardiol，2011，15，57(11):e101-e198.\[2\] Zimetbaum PJ. Dronedarone for atrial fibrillation—an odyssey\[J\].N Engl J Med,2009, 360（18）:1811-1813.\[3\] Podrid PJ.Amiodarone：reevaluation of an old drug\[J\]. Ann Intern Med，1995,122(9):689-700.\[4\] Kber L, TorpPedersen C, McMurray JJ, et al.Increased mortality after dronedarone therapy for severe heart failure\[J\]. N Engl JMed，2008，358(25):2678-2687.\[5\] Davy JM, Herold M, Hoglund C,et al.Dronedarone for the control of ventricular rate in permanent atrial fibrillation:The efficacy and safety of dronedarone for the control of ventricular rate during atrial fibrillation (ERATO)study\[J\].Am Heart J，2008，156(3):5271-5279.\[6\] Singh BN,Connolly SJ,Crijns HJ,et al.Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter\[J\].N Engl J Med，2007，357(10)：987-999.\[7\] Hohnloser SH,Crijns HJ,van Eickels M,et al.Effect of dronedarone on cardiovascular events in atrial fibrillation\[J\].N Engl J Med, 2009, 360(7)：668-678.\[8\] Pisters R, Hohnloser SH, Connolly SJ, et al. Effect of dronedarone on clinical end points in patients with atrial fibrillation and coronary heart disease: insights from the ATHENA trial \[J\]. Europace，2014，16(2)：174-181.\[9\] Le Heuzey JY, De Ferrari GM, Radzik D，et al.A shortterm, randomized, doubleblind, parallelgroup study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study\[J\].J Cardiovasc Electrophysiol，2010,21(6):597-605.\[10\] Connolly SJ, Camm AJ, Halperin JL，et al. Dronedarone in highrisk permanent atrial fibrillation \[J\]. N Engl J Med, 2011,365(24):2268-2276.\[11\] Nieuwlaat R，Eurlings LW，Cleland JG，et al. Atrial fibrillation and heart failure in cardiology practice: reciprocal impact and combined management from the perspective of atrial fibrillation: results of the Euro Heart Survey on atrial fibrillation \[J\]. J Am Coll Cardiol, 2009，53(18):1690-1698.\[12\] Roy D, Talajic M, Nattel S,et al.Rhythm control versus rate control for atrial fibrillation and heart failure\[J\]. N Engl J Med, 2008, 358(25):2667-2677.\[13\] TorpPedersen C, Moller M,BlochThomsen PE,et al.Dofetilide in patients with congestive heart failure and left ventricular dysfunction.Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group\[J\].N Engl J Med,1999,341(12):857-865.\[14\] Singh SN,Fletcher RD,FisherSG,et al.Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia.Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure\[J\].N Engl J Med,1995,333(2):77-82.\[15\] Hohnloser SH, Connolly SJ, John Camm A, et al. An individual patientbased metaanalysis of the effects of dronedarone in patients with atrial fibrillation\[J\].Europace, 2014,16(8):1117-1124.\[16\] Friberg L. Safety of dronedarone in routine clinical care\[J\]. J Am Coll Cardiol，2014，63(22):2376-2384.\[17\] Piccini JP, Hasselblad V,Peterson ED,et al.Comparative efficacy of droneadarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation\[J\].J Am Coll Cardiol, 2009,54(12):1089-1095.\[18\] Sohns C, von Gruben V, Sossalla S,et al.Antiarrhythmic drug therapy for maintaining sinus rhythm early after pulmonary vein ablation in patients with symptomatic atrial fibrillation\[J\].Cardiovasc Ther，2014，32(1):7-12.\[19\] Chun KJ, Byeon K, Im SI, et al.Efficacy of dronedarone versus propafenone in the maintenance of sinus rhythm in patients with atrial fibrillation after electrical cardioversion \[J\].Clin Ther，2014，36(9):1169-1175.
2014, Vol. 23 
